Author

Maxime Dhainaut

Icahn School of Medicine at Mount SinaiORCID 0000-0003-3832-7095Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

Agnieszka Zelisko-Schmidt· 1 shared Alessia BaccariniiD· 1 shared Alexander TepperiD· 1 shared Anne-Clémence Veillard· 1 shared Benoît VanhollebekeiD· 1 shared Bhavya SinghiD· 1 shared Brian D. BrowniD· 1 shared Céline Sabatel· 1 shared

Activity by Year

2018-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Agnieszka Zelisko-Schmidt

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJun 11, 2025

Plasminogen activator inhibitors orchestrate the immunosuppressive tumor microenvironment in pancreatic cancer

Chiara Falcomatà, Sebastian Rune Nielsen, Maximilian M. Schaefer…·Brian D. Brown

This study identifies Serpinb2 and Serpine1 as key factors in pancreatic cancer that remodel the tumor microenvironment to promote immune evasion and tumor progression.

1 citation

mousebulk RNA-seq

𝕏 PostBluesky

Molecular BiologybioRxivPreprintDec 4, 2018

Towards best-practice approaches for CRISPR/Cas9 gene engineering

Claude Van Campenhout, Pauline Cabochette, Anne-Clémence Veillard…·Véronique Kruys

The paper provides guidelines and tools to optimize CRISPR/Cas9 genome targeting efficiency and specificity by considering target locus, guide RNA design, delivery methods, and off-target detection.

DOI 10.1101/469544

experimental assaybenchmarking

𝕏 PostBluesky